Building Your Toolkit: How to Operationalize FDA Guidance on Diversity

In this discussion, team members from PCM Trials and EmVenio Research, a PCM Trials company, explore recent FDA guidance on diversity and share how community-based research models improve accessibility to help achieve diversity benchmarks in clinical trials. Learn how mobile visits and community sites deliver patient-centric solutions to remove barriers to participation and improve retention while meeting regulatory goals. This webinar offers valuable insights on designing clinical trials that expand reach, foster inclusivity, and improve trial outcomes.